Volume 24, Number 3—March 2018
Synopsis
Multistate Epidemiology of Histoplasmosis, United States, 2011–20141
Table 3
Patient factors associated with hospitalization or death among histoplasmosis cases reported to public health, 12 US states, 2011–2014*
Characteristic |
Hospitalization |
Death |
|||
RR (95% CI) |
p value |
RR (95% CI) |
p value |
||
Age >50 y | 1.23 (1.14–1.32) | <0.001 | 6.28 (3.43–11.49) | <0.001 | |
Male sex | 1.08 (1.01–1.45) | 0.033 | 1.02 (0.65–1.58) | 0.944 | |
Nonwhite race† | 1.26 (1.13–1.41) | <0.001 | 0.82 (0.36–1.86) | 0.627 | |
Immunocompromised‡ |
1.78 (1.62–1.96) |
<0.001 |
6.07 (2.61–14.11) |
<0.001 |
|
Positive laboratory test result§ | |||||
Antigen | 1.75 (1.62–1.89) | 0.001 | 1.73 (1.04–2.87) | 0.033 | |
Antibody | 0.58 (0.53–0.63) | <0.001 | 0.41 (0.24–0.71) | 0.001 | |
Confirmatory | 1.21 (1.09–1.34) | 0.001 | 2.13 (1.28–3.54) | 0.003 |
*RR, relative risk.
†Data collected by 8 states.
‡Data collected data by 3 states.
§Data collected by 9 states.
Page created: February 15, 2018
Page updated: February 15, 2018
Page reviewed: February 15, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.